| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Seeger H et al. | Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. | 2001 Jan-Feb | Menopause | pmid:11201515 |
| Walker RJ et al. | The effects of sequential combined oral 17beta-estradiol norethisterone acetate on insulin sensitivity and body composition in healthy postmenopausal women: a randomized single blind placebo-controlled study. | 2001 Jan-Feb | Menopause | pmid:11201511 |
| Margen S and King JC | Effect of oral contraceptive agents on the metabolism of some trace minerals. | 1975 | Am. J. Clin. Nutr. | pmid:1119435 |
| Prasad AS et al. | Effect of oral contraceptive agents on nutrients: I. Minerals. | 1975 | Am. J. Clin. Nutr. | pmid:1119434 |
| Sørensen MB et al. | Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. | 2001 | Am. J. Obstet. Gynecol. | pmid:11174477 |
| Cardim HJ et al. | The insulin-like growth factor-I system and hormone replacement therapy. | 2001 | Fertil. Steril. | pmid:11172828 |
| Teede HJ et al. | Effects of oral combined hormone replacement therapy on platelet aggregation in postmenopausal women. | 2001 | Clin. Sci. | pmid:11171290 |
| McGuire JL et al. | Effects of low dose oral contraceptives containing norethindrome and ethinyl estradiol on serum levels of progesterone and pituitary gonadotropins. | 1975 | Contraception | pmid:1116369 |
| Bai J et al. | Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. | 2000 | Cell | pmid:11163181 |
| Schoonen WG et al. | Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives. | 2000 | J. Steroid Biochem. Mol. Biol. | pmid:11162927 |
| Gravholt CH et al. | Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids. | 2001 | Am. J. Physiol. Endocrinol. Metab. | pmid:11158935 |
| Alexandersen P et al. | Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11158042 |
| Doyle LL | Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115155 |
| Plumb JM and Guest JF | Economic impact of tibolone compared with continuous-combined hormone replacement therapy. In the management of postmenopausal women with climacteric symptoms in the UK. | 2000 | Pharmacoeconomics | pmid:11151401 |
| Chihal HJ et al. | Estrogen potency of oral contraceptive pills. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115120 |
| Cornu C et al. | Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial. | 2000 | Maturitas | pmid:11137328 |
| Shojania AM et al. | The effect of oral contraceptives on folate metabolism. III. Plasma clearance and urinary folate excretion. | 1975 | J. Lab. Clin. Med. | pmid:1113011 |
| Speroff L et al. | The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms. | 2000 Nov-Dec | Menopause | pmid:11127760 |
| Briggs MH and Briggs M | Thiamine status and oral contraceptives. | 1975 | Contraception | pmid:1112084 |
| Björn I et al. | Negative mood changes during hormone replacement therapy: a comparison between two progestogens. | 2000 | Am. J. Obstet. Gynecol. | pmid:11120505 |